BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 9168687)

  • 1. New drugs for improving injury outcome in spinal cord injuries.
    Werner PC
    West J Med; 1997 Apr; 166(4):271-2. PubMed ID: 9168687
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical applications of pharmacologic therapies for spinal cord injury.
    Zeidman SM; Ling GS; Ducker TB; Ellenbogen RG
    J Spinal Disord; 1996 Oct; 9(5):367-80. PubMed ID: 8938604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promising pharmacological agents in the management of acute spinal cord injury.
    Seidl EC
    Crit Care Nurs Q; 1999 Aug; 22(2):44-50. PubMed ID: 10646442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological management of acute spinal cord injury.
    Sharma A
    J Assoc Physicians India; 2012 May; 60 Suppl():13-8. PubMed ID: 23155791
    [No Abstract]   [Full Text] [Related]  

  • 5. Promising pharmacological agents in the management of acute spinal cord injury.
    Seidl EC
    Pharm Pract Manag Q; 2000 Apr; 20(1):21-7. PubMed ID: 10947539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study.
    Bracken MB; Shepard MJ; Holford TR; Leo-Summers L; Aldrich EF; Fazl M; Fehlings M; Herr DL; Hitchon PW; Marshall LF; Nockels RP; Pascale V; Perot PL; Piepmeier J; Sonntag VK; Wagner F; Wilberger JE; Winn HR; Young W
    JAMA; 1997 May; 277(20):1597-604. PubMed ID: 9168289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological therapy for acute spinal cord injury.
    Hurlbert RJ; Hadley MN; Walters BC; Aarabi B; Dhall SS; Gelb DE; Rozzelle CJ; Ryken TC; Theodore N
    Neurosurgery; 2015 Mar; 76 Suppl 1():S71-83. PubMed ID: 25692371
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute spinal cord injury: pharmacotherapy and drug development perspectives.
    Blight AR; Zimber MP
    Curr Opin Investig Drugs; 2001 Jun; 2(6):801-8. PubMed ID: 11572660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trials of pharmacotherapy for spinal cord injury.
    Geisler FH
    Ann N Y Acad Sci; 1998 Jun; 845():374-81. PubMed ID: 9668370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial.
    Bracken MB; Shepard MJ; Holford TR; Leo-Summers L; Aldrich EF; Fazl M; Fehlings MG; Herr DL; Hitchon PW; Marshall LF; Nockels RP; Pascale V; Perot PL; Piepmeier J; Sonntag VK; Wagner F; Wilberger JE; Winn HR; Young W
    J Neurosurg; 1998 Nov; 89(5):699-706. PubMed ID: 9817404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinal cord injury.
    Geisler FH; Coleman WP; Benzel E; Ducker T; Hurlbert RJ
    Lancet; 2002 Dec; 360(9348):1883; author reply 1884. PubMed ID: 12480389
    [No Abstract]   [Full Text] [Related]  

  • 12. Steroids for acute spinal cord injury.
    Bracken MB
    Cochrane Database Syst Rev; 2012 Jan; 1(1):CD001046. PubMed ID: 22258943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Summary statement: the Sygen(GM-1 ganglioside) clinical trial in acute spinal cord injury.
    Fehlings MG; Bracken MB
    Spine (Phila Pa 1976); 2001 Dec; 26(24 Suppl):S99-100. PubMed ID: 11805615
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug development in spinal cord injury: what is the FDA looking for?
    Hall ED
    J Rehabil Res Dev; 2003; 40(4 Suppl 1):81-91. PubMed ID: 15077652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylprednisolone and other confounders to spinal cord injury clinical trials.
    Sipski ML; Pearse DD
    Nat Clin Pract Neurol; 2006 Aug; 2(8):402-3. PubMed ID: 16932592
    [No Abstract]   [Full Text] [Related]  

  • 16. AIT-082 and methylprednisolone singly, but not in combination, enhance functional and histological improvement after acute spinal cord injury in rats.
    Jiang S; Khan MI; Middlemiss PJ; Lu Y; Werstiuk ES; Crocker CE; Ciccarelli R; Caciagli F; Rathbone MP
    Int J Immunopathol Pharmacol; 2004; 17(3):353-66. PubMed ID: 15461869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of methylprednisolone and ganglioside GM-1 on a spinal lesion: a functional analysis.
    Carvalho MO; Barros Filho TE; Tebet MA
    Clinics (Sao Paulo); 2008 Jun; 63(3):375-80. PubMed ID: 18568249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [High-dose methylprednisolone in acute spinal injury].
    Sørensen P
    Ugeskr Laeger; 2008 Jan; 170(5):315-7. PubMed ID: 18252155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Truth--a question of belief].
    Brennum J; Dahl JB
    Ugeskr Laeger; 2008 Jan; 170(5):313. PubMed ID: 18252154
    [No Abstract]   [Full Text] [Related]  

  • 20. [Methylprednisolone in the treatment of acute spinal cord injury has become more and more questioned].
    Kronvall E; Sayer FT; Nilsson OG
    Lakartidningen; 2005 Jun 13-26; 102(24-25):1887-8, 1890. PubMed ID: 16044768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.